Compliance of COPD patients to their treatment

R. Dogan, B. E. Gulbay, O. U. Gurkan, Z. Ekici, G. Demir, O. Akkoca, T. Acican, S. Saryal, G. Karabiyikoglu (Ankara, Turkey)

Source: Annual Congress 2003 - Oxygen therapy in chronic respiratory care
Session: Oxygen therapy in chronic respiratory care
Session type: Thematic Poster Session
Number: 1619
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Dogan, B. E. Gulbay, O. U. Gurkan, Z. Ekici, G. Demir, O. Akkoca, T. Acican, S. Saryal, G. Karabiyikoglu (Ankara, Turkey). Compliance of COPD patients to their treatment. Eur Respir J 2003; 22: Suppl. 45, 1619

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Compliance with nebulized therapy in patients with chronic lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001

Impact of home hospitalization on treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001

Adherence of stable COPD patients to inhaled pharmacotherapy
Source: Annual Congress 2011 - COPD management
Year: 2011


Compliance for NIMV treatment in moderate and severe OSAS patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012

COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021


Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012


Life-sustaining treatment preferences of patients with severe COPD
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010


Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations
Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019
Year: 2019



Compliance index among patients with mild asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008


Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015

Hospital treatment costs of exacerbations in COPD patients with indications for LTOT
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


A realistic study assessing inhaled treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001

Adherence to home-based pulmonary rehabilitation among COPD patients
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021


Sputum assessment in asthma management does not improve disease control when GINA step-up treatment is used in mild-to-moderate patients
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


Comparison of initial drug treatment of incident COPD patients with German treatment guidelines
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019